AR glasses redefine telehealth visits, AI tackles healthcare’s biggest bottlenecks, and a health tech startup triples its valuation in four months.
September brought another month of firsts and fast-moving innovation in digital health. Augmented reality glasses are giving clinicians a patient’s-eye view during virtual visits, while AI is helping patients access same-day care and speeding up historically manual workflows across the care journey. Meanwhile, CMS and the FDA are pushing more technology-supported care into the home, and investors continue placing major bets on the infrastructure behind healthcare delivery.
But as AI takes on a bigger role in clinical care, some of the industry’s biggest questions are shifting from what the technology can do to who governs it—and who is responsible when it acts.
Here’s what’s driving digital health forward this month.
🤖 Technology, news, and insights
Mass General Brigham's AI intake agent gets patients seen the same day, 77% of the time.
Mass General Brigham is using an AI-powered intake agent within MyChart to help patients navigate primary care. According to the health system, the platform served 36,000 patients during its first year and now handles roughly 150 patients per day. Seventy-seven percent of patients using the tool connect with a physician the same day.
Read the full Becker's Hospital Review article here >>
XRHealth launches AR glasses that let clinicians see what patients see
XRHealth launched augmented reality glasses designed to take telehealth beyond the traditional video visit. During a live session, clinicians can remotely connect with patients, see care from the patient's perspective and provide real-time guidance while they interact with their physical environment. Read the full Computer Weekly article here >>
Kneu Health brings Parkinson’s monitoring to Apple Watch
Kneu Health launched an Apple Watch tool that tracks tremor and dyskinesia throughout the day. The watch data works alongside motor and cognitive assessments in its smartphone app, giving patients and clinicians a fuller picture of how symptoms change between appointments. The goal is to help care teams spot changes earlier and make more informed treatment decisions.
Read the announcement from Kneu Health >>
⚖️ Policy and regulatory
CMS Expands Technology-Supported Chronic Care Through ACCESS Model
CMS announced that its ACCESS Model will expand to include people with heart failure, chronic obstructive pulmonary disease, substance use disorders, and nicotine dependence. Beginning in spring 2027, eligible Original Medicare beneficiaries will have access to technology-supported care designed to help manage chronic conditions from home.
Read the full CMS announcement here >>
FDA advances home-based medical device innovation
The FDA announced its list of participants moving into the next phase of its READI-Home Innovation Challenge, an initiative designed to accelerate medical devices that could help patients transition safely from the hospital to home. The challenge focuses on technologies that could support patients and caregivers following an acute hospital stay and potentially reduce avoidable readmissions.
Read the full FDA announcement here >>
🗣️ Industry conversations
Healthcare's AI adoption is outpacing its governance, new index finds
A new Healthcare AI Readiness Index from Cotiviti and MedCity News found that healthcare organizations are adopting AI faster than they're building the governance and cybersecurity frameworks needed to use it safely. More than 70% of surveyed payer and provider respondents have already begun using AI tools, with nearly 40% of health insurers describing it as a core part of their business. The findings suggest healthcare's next phase of AI adoption will hinge less on who deploys it and more on who governs it well. Read the full Cotiviti announcement here >>
The next question for autonomous healthcare AI: who carries the liability?
As ARPA-H moves forward with its $62.7 million initiative to develop autonomous AI agents for heart failure care, health system leaders are raising a more complicated question: who is accountable when an autonomous system makes a clinical decision? The debate spans liability, human oversight, escalation and how responsibility should be divided among clinicians, health systems and technology developers. Becker's Hospital Review
Read the full Becker’s Hospital Review article here>>
📈 Growth, funding, and innovation
DexCare acquires Mila Health to add AI care coordination
Seattle-based DexCare, a patient access platform that spun out of Providence Health, acquired Mila Health, whose AI agents call, text, and chat with patients to get them scheduled and seen. Mila's agents reportedly get a 54% patient response rate on outbound outreach — 80% higher than manual call centers — and have cut no-show rates by half for the health systems using it. It's DexCare's second acquisition as it builds out a fuller AI-driven patient access platform.
Read the full GeekWire article here >>
Basalt Health raises $20M to speed up post-acute care placements
Basalt Health raised $20 million in Series A funding to expand its AI platform for post-acute care admissions. The technology analyzes referrals from faxes, portals and EHRs and matches patients with appropriate facilities based on clinical and payer requirements.At Lifepoint Health, Basalt says its platform has cut median chart processing time from 8.5 minutes to 1.2 minutes, with expansion to 49 additional Lifepoint markets planned by the end of 2026.
Read the full Fierce Healthcare article here >>
Forus raises $150M, tripling its valuation to $3B in just four months
Health tech startup Forus raised $150 million in Series C funding, just four months after closing a $160 million Series B. The latest round triples the company’s valuation to $3 billion as it expands its AI-powered prescription access network into more specialties and care settings. The company says its platform is now used by thousands of medical practices and health systems across all 50 states and reaches patients in 85% of U.S. residential ZIP codes.
Read the full Fierce Healthcare article here >>
📚 OpenLoop resources & news
OpenLoop partnership brings blood-based breast cancer screening to women across 48 states
Astrin Biosciences partnered with OpenLoop® Health to expand access to Certitude™, a non-imaging blood test for supplemental breast cancer screening, to eligible women across 48 states. Through OpenLoop's telehealth infrastructure, women can access the test through a digital care experience, helping extend screening options beyond traditional in-person pathways. Read the full press release here >>
Top 16 digital health conferences to attend in 2027
Planning your 2027 conference calendar? OpenLoop's new guide rounds up the 16 digital health events worth prioritizing next year — from CES's Digital Health Summit in January through HIMSS27, ViVE, HLTH, and Behavioral Health Tech's December close-out. Each entry includes dates, location, who typically shows up, and a quick read on whether it's worth the trip, so teams can plan their year around AI, virtual care, and health IT strategy without digging through a dozen separate event sites.
Read the full OpenLoop guide here >>



